Page 258 - fbkCardioDiabetes_2017
P. 258

234                      Cardio Diabetes Medicine 2017







                                     Remnant Lipo Proteins –


                                      Residual Vascular Risk






                                                  Dr. R. Sarvanan, MD.,
                                              Chairman, R.R.Hospital ,Thoothukudi






              ABSTRACT:
              This  article focusses  on the Remnant  Lipoproteins
              levels and the Residual vascular risks associated. In-
              vitro animal studies and various observational studies
              clearly show increased levels of Remnant Cholesterol
              causes atherosclerosis in the same way as increased
              LDL cholesterol. They also show that elevated LDL-C
              are  associated  with atherosclerotic vascular events
              but increased levels of RLP s is also correlated with
              low grade  inflammation.  They  are  measured  in the
              nonfasting state as  Total Cholesterol  minus LDL-C
              minus HDL-C.Even an increment of 39 mg/dl is asso-
              ciated with 2.8 fold increase in incidence of vascular
              events.
              Randomised trials  using fibrates  for  elevated tri-
              glyceride  levels  slow  benefits.  However  large  ran-
              domised trials with primary target of lo wering RLP s                              C-CHOLESTEROL
              are still missing even                             T-TRIGLYCERIDES
              though so  many new Therapeutic  perspectives  are   Lipoproteins  transport water insoluble Triglycerides
              in the pipeline                                    and  cholesterol  between tissues  and  organs  in the
                                                                 body. They consist of a core of Hydrophobic choles-
              Definition and Introduction                        terol  esters  and triglycerides  surrounded  by  Hydro-
              Despite  the success of statins in reducing athero-  philic monolayer  of Phospholipids,  free  cholesterol
              sclerotic cardiovascular disease  (ASCVD) there  re-  and apolipoproteins .
              mains a large residual risk for recurrent events even   The different classes are Chylomicrons, Chylomicron
              in statin treated patients. Although residual risk may   Remnants  Very  Low  Density  Lipoproteins(VLDL)  In-
              be attributable to many factors like Diabetes,Obesi-  termediate Density lipoproteins (IDL) LDL, Lipopro-
              ty,Alcoholism there  is  considerable  interest  in Lipo-  tein (a) and High Density Lipoprotein (HDL).
              protein related residual risk beyond LDL-C Reduction.
              Triglycerides  (TGL), a surrogate  marker  of  TG-rich
              remnant  Lipoprotein  have  been a particular source
              of interest because of consistent  association  with
              ASCVD  and the increase  in TG levels  in relation  to
              the Obesity Epidemic.






                                                         GCDC 2017
   253   254   255   256   257   258   259   260   261   262   263